ask Ask a question
Favorite

The measurement of DOX accumulation in cells was performed according to the method in [19]. Cells were seeded on microscope imaging chambers at a concentration of 2 × 106 cells/mL. Then the chambers were placed on the microscope stage. To study the effect of glycoside on the time course of DOX accumulation, EAC cells were pre-exposed to different concentrations of CA2-2 for 30 min before being mounted in the microscope stage. DOX at a final concentration of 5 μM were added to the cells and serial images at 1-min intervals were collected for 2 h and analyzed using a confocal microscope Axiovert 200M LSM510 META (Carl Zeiss, Germany). Doxorubicin fluorescence was excited with an argon laser at 488 nm, and the emission was collected through a 505-nm long-pass filter. Post-data acquisition image analysis was performed using LSM 510 software release version 4.2 (Carl Zeiss, Germany). Cell images were analyzed as mean DOX fluorescent intensity per pixel in a region of interest (nuclei). Results were obtained from analyzing images from three to five experiments.

To study of doxorubicin efflux (retention), EAC cells were seeded to a 24-well plate. Different concentrations of CA2-2 were added to each well and plates were incubated at 37 °C for 30 min to block MDR. Then, DOX (5 μM, final concentration) was added and plates were incubated for 2 h at 37 °C to accumulate doxorubicin in the cells. After a certain time, aliquots of 100 μL of the cell suspension were transferred into a 1.5 mL Eppendorf tube, pelleted by centrifugation, and washed twice with cold PBS. Then 100 μL of cell suspension was replaced with a black 96-well microplate and the fluorescence of doxorubicin was measured using a Fluoroscan Accent (Finland) plate reader at λex = 485 nm and λem = 620 nm.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A